Romanian private healthcare network MedLife has reached a market capitalisation of €1 billion at the Bucharest Stock Exchange (BVB), around nine years after the company went public.
MedLife, Romania's largest private healthcare network, announced financial results for the first nine months of 2025. The group recorded consolidated pro-forma revenue of over RON 2.36 billion (€464 million), up 19.5% compared to the same period in 2024. EBITDA pro-forma increased by 20.4% compared to the first nine months of last year.
Romanian private healthcare operator MedLife has reported a pro-forma consolidated turnover of RON 1.57 billion (€316 million) in H1 2025, a 20.3% increase compared to the same period in 2024.
Romanian private healthcare network MedLife is investing €3 million in genetic testing and will launch a large-scale genetic testing program.
Romanian private healthcare services provider MedLife has recorded a 20% y/y increase in pro-forma consolidated turnover during Q1 2025.
Romanian authorities are making over €8 billion available this summer in EU funds and state aid for businesses and local public authorities, according to REI analysis, a consultancy group specialising in attracting non-reimbursable financing.
The National Road Investment Company (CNIR) has capitalised on European financial frameworks by signing the first two infrastructure contracts for the A8 Unirii (Union) Motorway.
A Russian Geran-2 combat drone breached Romanian airspace and crashed into a residential apartment block in the eastern city of Galați early on 29 May, intensifying security concerns along NATO's eastern flank.
Christian Tour, one of Romania's largest tour operators, has successfully completed its initial public offering (IPO), ahead of its listing on the BVB.
Electro-Alfa International, a Romanian manufacturer of electrical equipment and provider of EPC and IT services, reported revenue growth and profitability for Q1 2026. The company's total revenues reached €25.7 million, up 12.2% compared to Q1 2025. Net profit increased by 2.9% to €6.2 million, supported by a 2% increase in EBITDA, which reached €10.6 million.